# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000310158-17-000045
Filing Date
2017-11-07
Accepted
2017-11-07 16:38:23
Documents
85
Period of Report
2017-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 3Q17 FORM 10-Q | mrk0930201710q.htm | 10-Q | 1977015
2 | EXHIBIT 31.1: RULE 13A-14(A)/15D-14(A) CERTIFICATION OF CEO 3Q17 | exhibit311rule13a-14a15dx1.htm | EX-31.1 | 8664
3 | EXHIBIT 31.2: RULE 13A-14(A)/15D-14(A) CERTIFICATION OF CFO 3Q17 | exhibit312rule13a-14a15dx1.htm | EX-31.2 | 8699
4 | EXHIBIT 32.1: SECTION 1350 CERTIFICATION OF CEO 3Q17 | exhibit321section1350certi.htm | EX-32.1 | 5202
5 | EXHIBIT 32.2: SECTION 1350 CERTIFICATION OF CFO 3Q17 | exhibit322section1350certi.htm | EX-32.2 | 5506
| Complete submission text file | 0000310158-17-000045.txt |  | 12292402

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL INSTANCE DOCUMENT | mrk-20170930.xml | EX-101.INS | 3887681
7 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | mrk-20170930.xsd | EX-101.SCH | 59226
8 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | mrk-20170930_cal.xml | EX-101.CAL | 95272
9 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | mrk-20170930_def.xml | EX-101.DEF | 306299
10 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | mrk-20170930_lab.xml | EX-101.LAB | 752649
11 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | mrk-20170930_pre.xml | EX-101.PRE | 466033

Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 908-740-4000
Merck & Co., Inc. (Filer) CIK: 0000310158 (see all company filings)

EIN.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-06571 | Film No.: 171183896
SIC: 2834 Pharmaceutical Preparations